Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Income from Continuing Operations (2016 - 2025)

Biomerica's Income from Continuing Operations history spans 16 years, with the latest figure at 1319000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 38.84% year-over-year to 1319000.0; the TTM value through Nov 2025 reached 4023000.0, up 28.22%, while the annual FY2025 figure was 4973000.0, 16.81% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 1319000.0 at Biomerica, down from 2000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 2000.0 in Q3 2025 and bottomed at 6673709.0 in Q2 2021.
  • The 5-year median for Income from Continuing Operations is 1524790.5 (2021), against an average of 1629320.65.
  • The largest annual shift saw Income from Continuing Operations plummeted 1483.98% in 2023 before it surged 100.15% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 1125274.0 in 2021, then tumbled by 44.52% to 1626254.0 in 2022, then rose by 7.33% to 1507000.0 in 2023, then soared by 36.96% to 950000.0 in 2024, then plummeted by 38.84% to 1319000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Income from Continuing Operations are 1319000.0 (Q4 2025), 2000.0 (Q3 2025), and 1544000.0 (Q2 2025).